Summary & Overview
HCPCS J1200: Diphenhydramine Injection, Up to 50 mg
HCPCS Level II code J1200 denotes the injectable formulation of diphenhydramine hydrochloride, up to 50 mg, used for antihistamine therapy in acute allergic reactions, premedication, or other clinical indications requiring parenteral administration. This code underpins billing for a commonly used, low-cost pharmacologic intervention across acute and ambulatory care settings and is relevant for payers and providers managing drug administration and encounter costs. Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn the clinical context for use of J1200, typical sites of service where the injection is delivered, and where available, benchmarking and coverage considerations affecting reimbursement and coding practice. The publication summarizes coding implications, common modifier usage patterns where applicable, and touches on billing scenarios such as administration in emergency departments, outpatient infusion areas, and physician offices. Data not available in the input are noted where relevant. The content serves clinicians, coding professionals, and policy analysts seeking a concise reference on the purpose and billing context of HCPCS Level II code J1200 at a national level.
Billing Code Overview
HCPCS Level II code J1200 represents an injection of diphenhydramine hydrochloride, up to 50 mg. This code is used to report administration of diphenhydramine by injection for indications such as allergic reactions, antihistamine therapy, or as premedication when clinically indicated.
-
Service type: Parenteral antihistamine administration (intramuscular or intravenous injection)
-
Typical site of service: Emergency department, outpatient clinic, physician office, urgent care, or other settings where injectable medications are administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 45-year-old patient presents to the emergency department with acute urticarial rash and pruritus after exposure to an environmental allergen. The triage nurse documents generalized hives and moderate itching without airway compromise. The attending emergency physician orders intramuscular diphenhydramine for prompt symptomatic relief. The medication is prepared and administered as J1200 (Injection, diphenhydramine HCl, up to 50 mg) via intramuscular route in the deltoid. Vital signs are monitored pre- and post-administration for sedation and hemodynamic stability. If symptoms persist or escalate, additional therapies (e.g., corticosteroid or epinephrine) are considered per protocol. Nursing documents lot number, dose, route, site, and patient response in the medical record. Billing is submitted using J1200 with applicable modifier if service circumstances require.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when an E/M visit is performed on the same day as administration and is distinct from the injection service. |